Why the study?
The association between epicardial adipose tissue thickness and cardiac dysfunction in individuals with severe obesity without known cardiovascular disease was unclear.
Is increased epicardial adipose tissue thickness associated with subclinical cardiac dysfunction in subjects with severe obesity without known cardiac disease?
Population
186 subjects aged 35 to 65 years referred for bariatric surgery without known cardiac disease
Comparison
Tertiles of EAT thickness: EAT-1 (<3.8 mm) vs EAT-2 (3.8-5.4 mm) vs EAT-3 (>5.4 mm)
Authors
Loading...
EAT thickness may flag early cardiac dysfunction in severe obesity; leaves open its value as a marker pending prospective validation.
Is increased epicardial adipose tissue thickness associated with subclinical cardiac dysfunction in subjects with severe obesity without known cardiac disease?
Increased epicardial adipose tissue thickness is independently associated with subclinical cardiac dysfunction (reduced GLS and LASct) in severely obese patients without known cardiovascular disease, suggesting its potential as an early marker.
Chin et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: